H1 results were in line with our estimates, with strong organic EBITDA growth compensating a lower than expected M&A contribution. Also, cash generation was strong resulting in a very sound financial position. We do not expect to make material changes to our estimates, but the results provide more comfort that our full year estimates will be achieved With more comfort on our estimates, the company delivering on its strategy, the share price down 20% since our previous downgrade, and 37% upside t ....
